247 related articles for article (PubMed ID: 33568627)
1. BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism.
Luo L; Sun W; Zhu W; Li S; Zhang W; Xu X; Fang D; Grahn THM; Jiang L; Zheng Y
Cell Death Dis; 2021 Feb; 12(2):169. PubMed ID: 33568627
[TBL] [Abstract][Full Text] [Related]
2. BCAT1, a key prognostic predictor of hepatocellular carcinoma, promotes cell proliferation and induces chemoresistance to cisplatin.
Zheng YH; Hu WJ; Chen BC; Grahn TH; Zhao YR; Bao HL; Zhu YF; Zhang QY
Liver Int; 2016 Dec; 36(12):1836-1847. PubMed ID: 27246112
[TBL] [Abstract][Full Text] [Related]
3. Branched-chain amino acid transaminase 1 (BCAT1) promotes the growth of breast cancer cells through improving mTOR-mediated mitochondrial biogenesis and function.
Zhang L; Han J
Biochem Biophys Res Commun; 2017 Apr; 486(2):224-231. PubMed ID: 28235484
[TBL] [Abstract][Full Text] [Related]
4. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of PRMT1 suppresses the malignant biological behavior of osteosarcoma cells and increases cisplatin sensitivity via c-Myc-mediated BCAT1 downregulation.
Li Z; Meng D; Liu Y; Bi F; Tian K; Xu J; Sun J; Gu C; Li Y
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23537. PubMed ID: 37700640
[TBL] [Abstract][Full Text] [Related]
6. Identification of mTOR as a primary resistance factor of the IAP antagonist AT406 in hepatocellular carcinoma cells.
Zhen MC; Wang FQ; Wu SF; Zhao YL; Liu PG; Yin ZY
Oncotarget; 2017 Feb; 8(6):9466-9475. PubMed ID: 28036295
[TBL] [Abstract][Full Text] [Related]
7. Arenobufagin, a natural bufadienolide from toad venom, induces apoptosis and autophagy in human hepatocellular carcinoma cells through inhibition of PI3K/Akt/mTOR pathway.
Zhang DM; Liu JS; Deng LJ; Chen MF; Yiu A; Cao HH; Tian HY; Fung KP; Kurihara H; Pan JX; Ye WC
Carcinogenesis; 2013 Jun; 34(6):1331-42. PubMed ID: 23393227
[TBL] [Abstract][Full Text] [Related]
8. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.
Yu L; Gu C; Zhong D; Shi L; Kong Y; Zhou Z; Liu S
Cancer Lett; 2014 Dec; 355(1):34-45. PubMed ID: 25236911
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
Shimizu S; Takehara T; Hikita H; Kodama T; Tsunematsu H; Miyagi T; Hosui A; Ishida H; Tatsumi T; Kanto T; Hiramatsu N; Fujita N; Yoshimori T; Hayashi N
Int J Cancer; 2012 Aug; 131(3):548-57. PubMed ID: 21858812
[TBL] [Abstract][Full Text] [Related]
10. Galectin-1-Induced Autophagy Facilitates Cisplatin Resistance of Hepatocellular Carcinoma.
Su YC; Davuluri GV; Chen CH; Shiau DC; Chen CC; Chen CL; Lin YS; Chang CP
PLoS One; 2016; 11(2):e0148408. PubMed ID: 26859293
[TBL] [Abstract][Full Text] [Related]
11. TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth.
Shen J; Lin H; Li G; Jin RA; Shi L; Chen M; Chang C; Cai X
Oncotarget; 2016 May; 7(22):32088-99. PubMed ID: 27050071
[TBL] [Abstract][Full Text] [Related]
12. Interconnections between autophagy and the coagulation cascade in hepatocellular carcinoma.
Chen KD; Wang CC; Tsai MC; Wu CH; Yang HJ; Chen LY; Nakano T; Goto S; Huang KT; Hu TH; Chen CL; Lin CC
Cell Death Dis; 2014 May; 5(5):e1244. PubMed ID: 24853422
[TBL] [Abstract][Full Text] [Related]
13. Isoquercitrin induces apoptosis and autophagy in hepatocellular carcinoma cells via AMPK/mTOR/p70S6K signaling pathway.
Shui L; Wang W; Xie M; Ye B; Li X; Liu Y; Zheng M
Aging (Albany NY); 2020 Nov; 12(23):24318-24332. PubMed ID: 33260158
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin induces autophagy to enhance hepatitis B virus replication via activation of ROS/JNK and inhibition of the Akt/mTOR pathway.
Chen X; Hu Y; Zhang W; Chen K; Hu J; Li X; Liang L; Cai X; Hu J; Wang K; Huang A; Tang N
Free Radic Biol Med; 2019 Feb; 131():225-236. PubMed ID: 30550853
[TBL] [Abstract][Full Text] [Related]
15. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of PI3K/Akt/mTOR pathway by apigenin induces apoptosis and autophagy in hepatocellular carcinoma cells.
Yang J; Pi C; Wang G
Biomed Pharmacother; 2018 Jul; 103():699-707. PubMed ID: 29680738
[TBL] [Abstract][Full Text] [Related]
17. Defect of branched-chain amino acid metabolism promotes the development of Alzheimer's disease by targeting the mTOR signaling.
Li H; Ye D; Xie W; Hua F; Yang Y; Wu J; Gu A; Ren Y; Mao K
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29802157
[TBL] [Abstract][Full Text] [Related]
18. Morin Hydrate Sensitizes Hepatoma Cells and Xenograft Tumor towards Cisplatin by Downregulating PARP-1-HMGB1 Mediated Autophagy.
Pal Singh M; Pal Khaket T; Bajpai VK; Alfarraj S; Kim SG; Chen L; Huh YS; Han YK; Kang SC
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158052
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
Cai S; Bai Y; Wang H; Zhao Z; Ding X; Zhang H; Zhang X; Liu Y; Jia Y; Li Y; Chen S; Zhou H; Liu H; Yang C; Sun T
J Exp Clin Cancer Res; 2020 Jul; 39(1):135. PubMed ID: 32669125
[TBL] [Abstract][Full Text] [Related]
20. Rage induces hepatocellular carcinoma proliferation and sorafenib resistance by modulating autophagy.
Li J; Wu PW; Zhou Y; Dai B; Zhang PF; Zhang YH; Liu Y; Shi XL
Cell Death Dis; 2018 Feb; 9(2):225. PubMed ID: 29445087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
